Literature DB >> 34392423

Giant Y79 retinoblastoma cells contain functionally active T-type calcium channels.

Sooyun Kim1, Segundo Jose Guzman2, Dong Hyun Jo3,4, Chang Sik Cho3, Jeong Hun Kim5,6,7.   

Abstract

Retinoblastoma is the most common malignant intraocular tumor in children. Y79 human retinoblastoma cells are in vitro models of retinal tumors used for drug screening. Undifferentiated Y79 cells originate from a primitive multi-potential neuroectodermal cell and express neuronal and glial properties. However, the nature of cellular heterogeneity in Y79 cells is unclear because functional methods to characterize neurons or glial cells have not been employed to Y79 cells. Here, we perform patch-clamp recordings to characterize electrophysiological properties in retinoblastoma cells. We identified a population of large-sized Y79 cells (i.e., giant cells, ~ 40-µm diameter), hyperpolarized resting membrane potential (-54 mV), and low input resistance (~ 600 MΩ), indicating electrically mature cells. We also found that giant Y79 cells contain increased density of T-type calcium channels. Finally, we found that T-type calcium channels are active only in giant cells suggesting that cancer treatments aimed to prevent calcium influx in retinoblastomas should be tested in giant cells.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cancer; Resting membrane potential; Retinoblastoma; T-type calcium channel; Y79

Mesh:

Substances:

Year:  2021        PMID: 34392423     DOI: 10.1007/s00424-021-02612-4

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   4.458


  39 in total

1.  The Ca(2+) channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms.

Authors:  Gabriel E Bertolesi; Chanjuan Shi; Lindsy Elbaum; Christine Jollimore; Gabriela Rozenberg; Steven Barnes; Melanie E M Kelly
Journal:  Mol Pharmacol       Date:  2002-08       Impact factor: 4.436

2.  Ca(v)3.1 splice variant expression during neuronal differentiation of Y-79 retinoblastoma cells.

Authors:  G E Bertolesi; R Walia Da Silva; C A B Jollimore; C Shi; S Barnes; M E M Kelly
Journal:  Neuroscience       Date:  2006-05-06       Impact factor: 3.590

Review 3.  Voltage-gated calcium channels.

Authors:  William A Catterall
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-08-01       Impact factor: 10.005

Review 4.  Calcium signaling and the therapeutic targeting of cancer cells.

Authors:  Alice H L Bong; Gregory R Monteith
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-05-26       Impact factor: 4.739

5.  Multipotential differentiation of human Y-79 retinoblastoma cells in attachment culture.

Authors:  G J Chader
Journal:  Cell Differ       Date:  1987-03

6.  A low voltage-activated, fully inactivating Ca channel in vertebrate sensory neurones.

Authors:  E Carbone; H D Lux
Journal:  Nature       Date:  1984 Aug 9-15       Impact factor: 49.962

Review 7.  The search for the retinoblastoma cell of origin.

Authors:  Michael A Dyer; Rod Bremner
Journal:  Nat Rev Cancer       Date:  2005-02       Impact factor: 60.716

8.  Low-voltage-activated calcium channels in human retinoblastoma cells.

Authors:  S Barnes; L W Haynes
Journal:  Brain Res       Date:  1992-12-11       Impact factor: 3.252

9.  Transplantation of Y79 cells into rat eyes: an in vivo model of human retinoblastomas.

Authors:  M del Cerro; G M Seigel; E Lazar; D Grover; C del Cerro; D H Brooks; D DiLoreto; G Chader
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-11       Impact factor: 4.799

Review 10.  Targeting calcium signaling in cancer therapy.

Authors:  Chaochu Cui; Robert Merritt; Liwu Fu; Zui Pan
Journal:  Acta Pharm Sin B       Date:  2016-12-13       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.